Skip Navigation

This Article
Right arrow Abstract
Right arrow FREE Full Text
Right arrow E-letters: Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-{alpha} inhibitor, in patients with advanced cancer
Ann Oncol Brown et al. 19: 1340

Supplementary Data

Data files

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow FREE Full Text
Right arrow E-letters: Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer